Conmed Corporation (CNMD) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Conmed Corporation  (NYSE: CNMD)


Conmed's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Conmed's ROI in the third quarter of 2026?
Conmed Corporation achieved a return on average invested assets (ROI) of 3.27 % in its third quarter of 2026, this is above CNMD's average return on investment of 2.45%.
Conmed Corporations investments during the 12 months ending in the third quarter of 2026 are valued at $2 billion

Despite the deterioration in its net income, company has improved ROI compared to the second quarter of 2026.

Within the Healthcare sector 160 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 1947 to 1997.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 10.53 % 6.61 % 2.93 % 4.67 % 4.29 %
Y / Y Net Income Change TTM 14.62 % -48.73 % -38.22 % -43.13 % 30.8 %
Investment (TTM) in Millions 2,512 2,533 1,941 2,011 2,076
Return On Investment (TTM) 3.27 % 2.64 % 2.7 % 2.3 % 3.15 %
CNMD's Overall Ranking # 1997 # 1947 # 1142 # 1536 #
Seq. Investment Change TTM 5.08 % 5.4 % -0.9 % 0.7 % 1.35 %
Seq. Net Income Change TTM 29.98 % 3.01 % 16.56 % -26.56 % -41.86 %
Net Income (TTM) in Millions 73 56 55 47 64

CNMD Company Profile >> Back to CNMD Roi Comparisons >> See Annual CNMD Return On Investment



Return On Investment CNMD's Ranking
Within: No.
Industry # 54
Sector # 161
Overall # 1997

Return On Investment Statistics
High Average Low
6.54 %
2.45 %
-6.89 %
(Dec 31 2024)   (Jun 30 2022)







Financial Statements
Conmed's III. Quarter Investments $ 2,512 Millions CNMD's Balance sheet
Conmed's III. Quarter Income $ 20 Millions Quarterly CNMD's Income Statement
CNMD's Income by Division See CNMD's Income by Division


CNMD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,931 1,954 1,928 1,934 1,501
Y / Y Investment Growth -1.17 % 1.33 % -0.31 % 28.88 % -0.18 %
Net Income in Millions 47 132 64 -81 63
Y / Y Net Income Growth -64.47 % 105.44 % - - 557.16 %
Annual Return On Investment 2.44 % 6.78 % 3.34 % -4.17 % 4.17 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 2.44 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CNMD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CNMD's Competitors
Subscribers only: Roi for Conmed's Suppliers
Subscribers only: Return On Investment for CNMD's Customers

Other Ratios
CNMD's Roa CNMD's Inventory Turnover Ratio CNMD's Growth Rates CNMD's Dividend Statistics
CNMD's Profitability Ratios CNMD's Asset Turnover Ratio CNMD's Dividend Growth
CNMD's Roe CNMD's Valuation Ratios CNMD's Financial Strength Ratios CNMD's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Stryker Corp  8.63 %
Pediatrix Medical Group Inc   8.37 %
Penumbra Inc  8.28 %
Medinotec Inc   8.12 %
Pacific Health Care Organization Inc  8.09 %
Quest Diagnostics Inc  8.01 %
Ge Healthcare Technologies Inc   7.60 %
Incyte Corporation  6.81 %
Lifevantage Corp  6.51 %
Merit Medical Systems Inc  6.21 %
Davita Inc   6.13 %
Black Hawk Acquisition Corporation  6.10 %
Iqvia Holdings Inc   6.09 %
Labcorp Holdings Inc   6.07 %
Pacs Group Inc   5.95 %
Ensign Group Inc  5.94 %
Amneal Pharmaceuticals Inc   5.59 %
Sotera Health Company  5.43 %
Henry Schein Inc   5.27 %
Abbott Laboratories  5.14 %
Haemonetics Corporation  4.85 %
Teleflex Incorporated  4.81 %
Lifestance Health Group Inc   3.71 %
U S Physical Therapy Inc  3.33 %
Conmed Corporation  3.16 %
Integer Holdings Corporation  3.13 %
Avantor Inc   3.11 %
Innovage Holding Corp   2.95 %
Ligand Pharmaceuticals Incorporated  2.84 %
Revvity Inc  2.35 %

Date modified: 2026-10-29T09:59:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.